Actavis Sheds Some Claims But Can't Exit Testosterone Trial
An Illinois federal judge has partially denied pharmaceutical giant Actavis' summary judgment motion and refused to bar certain expert testimony in what was to have been the first bellwether trial against...To view the full article, register now.
Already a subscriber? Click here to view full article